John Varian - Jun 22, 2023 Form 4 Insider Report for Acorda Therapeutics, Inc. (ACOR)

Role
Director
Signature
/s/ John Varian
Stock symbol
ACOR
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 05:38 PM
Previous filing
Feb 3, 2023
Next filing
Jan 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Non-Employee Stock Option Award $0 +1.2K $0.00 1.2K Jun 22, 2023 Common Stock 1.2K $12.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 22, 2023, with the first quarterly installment vesting on September 22, 2023, subject to continued service on the company's Board of Directors through each vesting date.